再発膠芽腫:グローバル臨床試験レビュー(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Recurrent Glioblastoma Multiforme (GBM) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Recurrent Glioblastoma Multiforme (GBM) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Recurrent Glioblastoma Multiforme (GBM) to Oncology Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Recurrent Glioblastoma Multiforme (GBM) 24
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Recurrent Glioblastoma Multiforme (GBM) Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Recurrent Glioblastoma Multiforme (GBM) 33
Mar 06, 2014: SeeThruEquity Issues Update on DelMar Pharmaceuticals, Inc.’s VAL-083 Clinical Trial 33
Mar 04, 2014: Cellectar Announces Initiation of Phase II Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma 33
Jan 13, 2014: Apogenix’ APG101 Demonstrates Significant Prolongation of Overall Survival in Biomarker-Positive Patients in Phase II Trial for the Treatment of Recurrent Glioblastoma 34
Jan 07, 2014: Apogenix to Present Phase II Results with APG101 for the Treatment of Recurrent Glioblastoma at Biotech Showcase in San Francisco 34
Dec 23, 2013: ImmunoCellular Therapeutics Announces First Patient Receives Vaccine in Phase I Trial of Cancer Vaccine ICT-121 in Recurrent Glioblastoma 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
F. Hoffmann-La Roche Ltd. 36
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 36
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Eli Lilly and Company 42
Clinical Trial Overview of Eli Lilly and Company 42
Eisai Co., Ltd. 43
Clinical Trial Overview of Eisai Co., Ltd. 43
Medicenna Therapeutics, Inc 44
Clinical Trial Overview of Medicenna Therapeutics, Inc 44
E. Merck KG 45
Clinical Trial Overview of E. Merck KG 45
Bristol-Myers Squibb Company 46
Clinical Trial Overview of Bristol-Myers Squibb Company 46
Clinical Trial Overview of Top Institutes / Government 47
National Cancer Institute 47
Clinical Trial Overview of National Cancer Institute 47
The University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 49
Duke University 50
Clinical Trial Overview of Duke University 50
Massachusetts General Hospital 51
Clinical Trial Overview of Massachusetts General Hospital 51
European Organization for Research and Treatment of Cancer 52
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 52
Rigshospitalet 53
Clinical Trial Overview of Rigshospitalet 53
Cedars-Sinai Medical Center 54
Clinical Trial Overview of Cedars-Sinai Medical Center 54
Case Comprehensive Cancer Center 55
Clinical Trial Overview of Case Comprehensive Cancer Center 55
University of Zurich 56
Clinical Trial Overview of University of Zurich 56
Five Key Clinical Profiles 57
Appendix 152
Abbreviations 152
Definitions 152
Research Methodology 153
Secondary Research 153
About GlobalData 154
Contact Us 154
Disclaimer 154
Source 155


【レポート販売概要】

■ タイトル:再発膠芽腫:グローバル臨床試験レビュー(2014年上半期)
■ 英文:Recurrent Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H1, 2014
■ 発行日:2014年4月15日
■ 調査会社:GlobalData
■ 商品コード:GDHC2079CTIDB
■ 調査対象地域:グローバル
  • 世界の電気手術デバイス市場動向(2012-2016)
    TechNavio's analysts forecast the Global Electrosurgical Devices market to grow at a CAGR of 5.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for minimally invasive surgery. The Global Electrosurgical Devices market has also been witnessing rapid advancements in technology. However, the risk of side effects could pose a chal …
  • 特殊化学品の世界市場分析:塗料、農薬、電子用、建設用
    The global specialty chemicals market is expected to reach USD 1.79 trillion by 2025, according to a new report by Grand View Research, Inc. Growing popularity of high-value chemicals that play a crucial role in the development of novel products is a major driving factor for the industry. Specialized & advanced features of these compounds lends them a significant advantage in comparison with commo …
  • メタロセンポリオレフィン(mPO)の世界市場予測(~2021)
    The market size of metallocene polyolefin is estimated to reach USD 14.05 Billion by 2021, growing at a CAGR of 10.15% during the forecast period. The market is driven by increasing global demand for quality resins, rise in packaging industry, food industry developments, and technological advances. The rising demand for meatllocene polyolefin is mainly due to its superior properties over the conve …
  • 産業制御/FA(ファクトリーオートメーション)の世界市場予測
    The convergence of the physical and the virtual worlds through Cyber-Physical-Systems (CPS), and the consequent fusion of business processes and technical processes have set the pace of the industrial control and factory automation concept. Industrial Control and Factory Automation brings lot of advantages such as improved efficiency and reduced costs compared to conventional manufacturing process …
  • 産業用溶接ロボットの世界市場2017-2021
    About industrial welding robotsThe industrial welding robots are programmed and are automatically-operated machines. These are being increasingly deployed in end-user industries for handling critical welding operations and ensuring the safety of manual workers in the industries. The end users are also looking at welding robots as a tool that helps them to improve the quality, efficiency, and produ …
  • 鉄道車両の世界市場:ディーゼル機関車、電気機関車
    About rolling stock Wheeled railway vehicles that move on tracks are referred to as rolling stock. The vehicles primarily include locomotives, passenger rail vehicles, and freight wagons. Some are propelled vehicles and some are self-propelled. These vehicles are capital-intensive products and their manufacturing involves huge investment and long time. Technavio's analysts forecast the global roll …
  • Asacol HD(潰瘍性大腸炎):市場分析と予測(~2022)
    Asacol HD (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecti …
  • カプサイシンの世界市場
    Capsaicin (CAS 404-86-4) Market Research Report 2014 presents comprehensive data on praduct markets globally and regionally (Europe, Asia, North America etc.) The report includes capsaicin description, covers its application areas and related patterns. It overviews capsaicin market, names capsaicin producers and indicates its suppliers. Besides, the report provides capsaicin prices in regional mar …
  • サリチル酸の世界市場2015-2019
    Technavio’s market research analyst predicts the global salicylic acid market to grow at a CAGR of around 9% during the forecast period. The increased use of salicylic acid in the manufacture of aspirin and its extensive application in the pharmaceutical sector is the primary driver for the growth of the market. The increased preference for preserved food and beverages among consumers is anticipat …
  • 食品接触紙/板紙の世界市場2015-2019
    About Food Contact Paper and Board Food contact paper and board are used to package food products such as bakery goods, fruits, beverages, and take-out foods. On the basis of type, food contact paper and board can be categorized into two: non-poly-coated paper and board and poly-coated paper and board. While non-poly-coated paper and board are used to package dry food items, poly-coated paper and …
  • カジノゲームの世界市場
    About Casino Gaming Casino is a place that hosts various types of gambling activities. Modern casino includes hotels, restaurants, shopping malls, and various other tourist attractions; it is an indoor amusement park. In casinos, the majority of the revenue comes from gambling. Gambling is illegal in many parts of the globe, making it a concentrated market. However, with the growing popularity and …
  • ナノエマルジョンの世界市場:種類別(小分子界面活性剤、タンパク質安定化エマルジョン、多糖類)、用途別(飲料、乳製品、ベーカリー)
    Emulsion can be described as an emulsion process that consists of at least one immiscible liquid dispersed in another liquid in the form of droplets, whose diameter exceeds 0.1 μm. Earlier emulsions were used in pharmaceutical and animal nutrition industries; however, their use in the food industry has grown noticeably in the past decade. Emulsion in the food is processed to make changes in its or …
  • 世界のエネルギーセキュリティー市場:Global Energy Security Market 2014-2018
    TechNavio's analysts forecast the Global Energy Security market to grow at a CAGR of 6.5 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased occurrence of cyber threats. The Global Energy Security market has also been witnessing the increase in the construction of smart grid. However, the unpredictability of cyber threats could pose a chall …
  • 人事アウトソーシング(HRO)のグローバル市場(2014-2018)
    About Human Resources Outsourcing HRO refers to the outsourcing of one or more HR functions by other businesses or organizations in order to reduce labor costs and maximize efficiency. The objective of HRO is to penetrate all the HR services including HR planning, system design, and innovation, flow integration, employees' degree of satisfaction, compensation planning, training, employee relations …
  • 採血の世界市場予測(~2022年):血清チューブ、血漿チューブ、EDTA、ヘパリン、凝固、ブドウ糖、針、ランセット、ESR、注射器、血液バッグ
    The global blood collection market is expected to account for USD 8.10 Billion in 2017 and is expected to grow at a CAGR of 5.5% to reach USD 10.59 Billion by 2022. The growing number of accidental and trauma cases, rising number of surgeries, emergence of liquid biopsy, rise in the demand for blood components, and increasing prevalence of various diseases are the factors driving market growth. Th …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。